intravesical tacrolimus
1 abstract
Abstract
The safety, tolerability and efficacy of LP-10 in subjects with refractory moderate to severe hemorrhagic cystitis: Phase 2a multicenter dose escalation clinical trial.Org: Lipella Pharmaceuticals, University of California San Francisco Department of Urology, Emory University School of Medicine, Baylor College of Medicine, Vanderbilt University Medical Center,